Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             179 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acceptance of a post-partum influenza vaccination (cocooning) strategy for neonates in Greece Maltezou, Helena C.
2012
30 Supplement 4 p. 5871-5874
4 p.
artikel
2 A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children Anh, Dang Duc
2012
30 Supplement 4 p. A114-A121
nvt p.
artikel
3 A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children Aquino, Amalia Guadalupe Becerra
2012
30 Supplement 4 p. 6492-6500
9 p.
artikel
4 A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed Pajewski, Nicholas M.
2012
30 Supplement 4 p. 4778-4784
7 p.
artikel
5 A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy Oppermann, Marc
2012
30 Supplement 4 p. 4445-4452
8 p.
artikel
6 Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) induced IgG1 and IgG4 antibody responses in young children Nakayama, Tetsuo
2012
30 Supplement 4 p. 7662-7666
5 p.
artikel
7 A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants Odutola, A.A.
2012
30 Supplement 4 p. 5591-5594
4 p.
artikel
8 An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP–IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children Klein, Nicola P.
2012
30 Supplement 4 p. 668-674
7 p.
artikel
9 An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women Jacobsen, Steven J.
2012
30 Supplement 4 p. 4585-4587
3 p.
artikel
10 A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil Weckx, Lily Yin
2012
30 Supplement 4 p. 7566-7572
7 p.
artikel
11 A possible relationship of natural killer T cells with humoral immune response to 23-valent pneumococcal polysaccharide vaccine in clinical settings Miyasaka, Tomomitsu
2012
30 Supplement 4 p. 3304-3310
7 p.
artikel
12 Ascaris suum enolase is a potential vaccine candidate against ascariasis Chen, Ning
2012
30 Supplement 4 p. 3478-3482
5 p.
artikel
13 A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain Thibodeaux, Brett A.
2012
30 Supplement 4 p. 3180-3187
8 p.
artikel
14 Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs Sanford, Brenton J.
2012
30 Supplement 4 p. 6249-6255
7 p.
artikel
15 Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life Wang, Yangyang
2012
30 Supplement 4 p. 5708-5713
6 p.
artikel
16 A subunit vaccine against hydropericardium syndrome using adenovirus penton capsid protein Shah, M.S.
2012
30 Supplement 4 p. 7153-7156
4 p.
artikel
17 A systematic review of rotavirus strain diversity in India, Bangladesh, and Pakistan Miles, Melody G.
2012
30 Supplement 4 p. A131-A139
nvt p.
artikel
18 A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009–2010 season Tennis, Patricia
2012
30 Supplement 4 p. 6099-6102
4 p.
artikel
19 Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1) Nayak, Baibaswata
2012
30 Supplement 4 p. 2220-2227
8 p.
artikel
20 A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose Richert, Laura E.
2012
30 Supplement 4 p. 3653-3665
13 p.
artikel
21 Bacillus atrophaeus inactivated spores as a potential adjuvant for veterinary rabies vaccine Oliveira-Nascimento, L.
2012
30 Supplement 4 p. 3351-3354
4 p.
artikel
22 Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice Jiang, Wenzheng
2012
30 Supplement 4 p. 758-766
9 p.
artikel
23 Bovine tuberculosis vaccine research: Historical perspectives and recent advances Waters, W. Ray
2012
30 Supplement 4 p. 2611-2622
12 p.
artikel
24 Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy Ansaldi, Filippo
2012
30 Supplement 4 p. 2288-2294
7 p.
artikel
25 Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice Dendouga, Najoua
2012
30 Supplement 4 p. 3126-3135
10 p.
artikel
26 Challenge with a hepatitis B vaccine in two cohorts of 4–7-year-old children primed with hexavalent vaccines: An open-label, randomised trial in Italy Zanetti, Alessandro
2012
30 Supplement 4 p. 5770-5775
6 p.
artikel
27 Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine Elberse, Karin E.M.
2012
30 Supplement 4 p. 7644-7651
8 p.
artikel
28 Characterizing providers’ immunization communication practices during health supervision visits with vaccine-hesitant parents: A pilot study Opel, Douglas J.
2012
30 Supplement 4 p. 1269-1275
7 p.
artikel
29 Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination Menon, Vinay J.
2012
30 Supplement 4 p. 3136-3144
9 p.
artikel
30 Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: A randomized, controlled, open-label, multicenter study Chatterjee, Archana
2012
30 Supplement 4 p. 3360-3368
9 p.
artikel
31 Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: Waning pertussis immunity in a highly immunized population and the need for adolescent booster doses Lai, F.Y.
2012
30 Supplement 4 p. 3566-3571
6 p.
artikel
32 Comparison of multiple estimates of efficacy for influenza vaccine Loeb, Mark
2011
30 Supplement 4 p. 1-4
4 p.
artikel
33 Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age Halperin, Scott A.
2012
30 Supplement 4 p. 2556-2563
8 p.
artikel
34 Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patients Lu, Ching-Lan
2012
30 Supplement 4 p. 3526-3533
8 p.
artikel
35 Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice Han, Ji Eun
2012
30 Supplement 4 p. 4127-4134
8 p.
artikel
36 Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice Fu, Shulin
2012
30 Supplement 4 p. 6839-6844
6 p.
artikel
37 Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source Gill, C.J.
2011
30 Supplement 4 p. 29-34
6 p.
artikel
38 Cost-effectiveness of hepatitis A vaccination for adults in Belgium Luyten, Jeroen
2012
30 Supplement 4 p. 6070-6080
11 p.
artikel
39 Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response Taylor, David N.
2012
30 Supplement 4 p. 5761-5769
9 p.
artikel
40 Differential effects of monophosphoryl lipid A and cytokine cocktail as maturation stimuli of immunogenic and tolerogenic dendritic cells for immunotherapy Raïch-Regué, Dàlia
2012
30 Supplement 4 p. 378-387
10 p.
artikel
41 Direct and indirect impact of influenza vaccination of young children on school absenteeism King Jr., James C.
2012
30 Supplement 4 p. 289-293
5 p.
artikel
42 Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain Hung, Ivan F.N.
2012
30 Supplement 4 p. 6427-6435
9 p.
artikel
43 Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis Shang, Shaobin
2012
30 Supplement 4 p. 1572-1582
11 p.
artikel
44 Early infection dynamics after experimental challenge with Mycobacterium avium subspecies paratuberculosis in calves reveal limited calf-to-calf transmission and no impact of Hsp70 vaccination Santema, Wiebren J.
2012
30 Supplement 4 p. 7032-7039
8 p.
artikel
45 Early-life and contemporaneous nutritional and environmental predictors of antibody response to vaccination in young Gambian adults Moore, Sophie E.
2012
30 Supplement 4 p. 4842-4848
7 p.
artikel
46 Editorial Board 2012
30 Supplement 4 p. CO2-
1 p.
artikel
47 Editorial Board 2012
30 Supplement 4 p. CO2-
1 p.
artikel
48 Editorial Board/Aims and Scope 2012
30 Supplement 4 p. CO2-
1 p.
artikel
49 Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience Djingarey, Mamoudou H.
2012
30 Supplement 4 p. B40-B45
nvt p.
artikel
50 Effectiveness and immunogenicity of pneumococcal vaccination in splenectomized and functionally asplenic patients Forstner, C.
2012
30 Supplement 4 p. 5449-5452
4 p.
artikel
51 Effectiveness of the 2010–2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case–case comparison, case-control study Puig-Barberà, J.
2012
30 Supplement 4 p. 5714-5720
7 p.
artikel
52 Effects of immunization with natural and recombinant lysine decarboxylase on canine gingivitis development Peters, Jennifer L.
2012
30 Supplement 4 p. 6706-6712
7 p.
artikel
53 Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.) Abd Alla, Mohamed D.
2012
30 Supplement 4 p. 3068-3075
8 p.
artikel
54 Efficacy of an AS03A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs De Vleeschauwer, Annebel R.
2012
30 Supplement 4 p. 5557-5563
7 p.
artikel
55 Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer Zhu, Daming
2012
30 Supplement 4 p. 189-194
6 p.
artikel
56 Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague Albrecht, Mark T.
2012
30 Supplement 4 p. 4872-4883
12 p.
artikel
57 Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles Garlapati, S.
2012
30 Supplement 4 p. 5206-5214
9 p.
artikel
58 Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell (DC) vaccine Kono, Masato
2012
30 Supplement 4 p. 2633-2639
7 p.
artikel
59 Enhancement of the immunogenicity of an alphavirus replicon-based DNA vaccine against classical swine fever by electroporation and coinjection with a plasmid expressing porcine interleukin 2 Tian, Da-Yong
2012
30 Supplement 4 p. 3587-3594
8 p.
artikel
60 Enhancing immune responses to inactivated porcine parvovirus oil emulsion vaccine by co-inoculating porcine transfer factor in mice Wang, Rui-ning
2012
30 Supplement 4 p. 5246-5252
7 p.
artikel
61 Epidemiology of invasive pneumococcal infection among hospitalized children aged less than 5 years in Oman Awaidy, Salah Thabit Al
2012
30 Supplement 4 p. G7-G10
nvt p.
artikel
62 Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB/c mice Christy, Aparna Josephine
2012
30 Supplement 4 p. 1364-1370
7 p.
artikel
63 Evaluating associations between sources of information, knowledge of the human papillomavirus, and human papillomavirus vaccine uptake for adult women in California Almeida, Cristina M.
2012
30 Supplement 4 p. 3003-3008
6 p.
artikel
64 Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model Goicochea, Marco A.
2012
30 Supplement 4 p. 1445-1452
8 p.
artikel
65 Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: Interim analysis Bettinger, Julie A.
2012
30 Supplement 4 p. 4023-4027
5 p.
artikel
66 Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice Sislema-Egas, Fernanda
2012
30 Supplement 4 p. 7286-7291
6 p.
artikel
67 Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates Boonnak, Kobporn
2012
30 Supplement 4 p. 5603-5610
8 p.
artikel
68 Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac Caron, François
2012
30 Supplement 4 p. 5059-5062
4 p.
artikel
69 Expression of infectious pancreatic necrosis virus (IPNV) VP2–VP3 fusion protein in Lactobacillus casei and immunogenicity in rainbow trouts Li-Li, Zhao
2012
30 Supplement 4 p. 1823-1829
7 p.
artikel
70 Feasibility of a randomized controlled trial to evaluate Text Reminders for Immunization Compliance in Kids (TRICKs) Ahlers-Schmidt, Carolyn R.
2012
30 Supplement 4 p. 5305-5309
5 p.
artikel
71 Field vaccination of sheep with a larval-specific antigen of the gastrointestinal nematode, Haemonchus contortus, confers significant protection against an experimental challenge infection Piedrafita, D.P.
2012
30 Supplement 4 p. 7199-7204
6 p.
artikel
72 Four years of universal pneumococcal conjugate infant vaccination in Germany: Impact on incidence of invasive pneumococcal disease and serotype distribution in children van der Linden, Mark
2012
30 Supplement 4 p. 5880-5885
6 p.
artikel
73 Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway Su, Fei
2012
30 Supplement 4 p. 4106-4112
7 p.
artikel
74 Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections Böttcher-Friebertshäuser, Eva
2012
30 Supplement 4 p. 7374-7380
7 p.
artikel
75 Heparanase DNA vaccine delivered by electroporation induces humoral immunity and cytoimmunity in animal models Fu, Jie
2012
30 Supplement 4 p. 2187-2196
10 p.
artikel
76 Heteroclitic peptides enhance human immunodeficiency virus-specific CD8+ T cell responses Gladney, Krista H.
2012
30 Supplement 4 p. 6997-7004
8 p.
artikel
77 Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization Dekker, C.N.T.
2012
30 Supplement 4 p. 1379-1387
9 p.
artikel
78 Hospitalized children with pneumonia in Uruguay: Pre and post introduction of 7 and 13-valent pneumococcal conjugated vaccines into the National Immunization Program Hortal, María
2012
30 Supplement 4 p. 4934-4938
5 p.
artikel
79 Immune response after one or two doses of pandemic influenza A (H1N1) monovalent, AS03-adjuvanted vaccine in HIV infected adults Nielsen, Allan Bybeck
2012
30 Supplement 4 p. 7067-7071
5 p.
artikel
80 Immunization with apoptotic pseudovirus transduced cells induces both cellular and humoral responses: A proof of concept study in macaques Koopman, Gerrit
2012
30 Supplement 4 p. 2523-2534
12 p.
artikel
81 Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice Brewoo, Joseph N.
2012
30 Supplement 4 p. 1513-1520
8 p.
artikel
82 Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine Porter, Kevin R.
2012
30 Supplement 4 p. 336-341
6 p.
artikel
83 Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2–10 years: A Phase II/III double-blind randomized controlled trial Hirve, Siddhivinayak
2012
30 Supplement 4 p. 6456-6460
5 p.
artikel
84 Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers Klein, Nicola P.
2012
30 Supplement 4 p. 3929-3936
8 p.
artikel
85 Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan Huang, Li-Min
2012
30 Supplement 4 p. 2054-2059
6 p.
artikel
86 Immunogenicity and safety of LBVH0101, a new Haemophilus influenzae type b tetanus toxoid conjugate vaccine, compared with Hiberix™ in Korean infants and children: A randomized trial Kim, Kyung-Hyo
2012
30 Supplement 4 p. 1886-1894
9 p.
artikel
87 Immunogenicity of a lentiviral-based DNA vaccine driven by the 5′LTR of the naturally attenuated caprine arthritis encephalitis virus (CAEV) in mice and macaques Arrode-Brusés, Géraldine
2012
30 Supplement 4 p. 2956-2962
7 p.
artikel
88 Immunogenicity of the pentavalent rotavirus vaccine in African infants Armah, George E.
2012
30 Supplement 4 p. A86-A93
nvt p.
artikel
89 Immunological impact of an additional early measles vaccine in Gambian children: Responses to a boost at 3 years Njie-Jobe, Jainaba
2012
30 Supplement 4 p. 2543-2550
8 p.
artikel
90 Improvac does not modify the expression and activities of the major drug metabolizing enzymes cytochrome P450 3A and 2C in pigs Tomankova, Jana
2012
30 Supplement 4 p. 3515-3518
4 p.
artikel
91 Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults Kikuchi, Tadashi
2012
30 Supplement 4 p. 3819-3823
5 p.
artikel
92 Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge Morello, Christopher S.
2012
30 Supplement 4 p. 6541-6550
10 p.
artikel
93 Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge Cox, Josephine H.
2012
30 Supplement 4 p. 1830-1840
11 p.
artikel
94 Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU®-Multi-HIVB, in untreated HIV-1 infected subjects Vardas, Eftyhia
2012
30 Supplement 4 p. 4046-4054
9 p.
artikel
95 Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo Daenthanasanmak, Anusara
2012
30 Supplement 4 p. 5118-5131
14 p.
artikel
96 Intranasal immunisation of mice against Streptococcus equi using positively charged nanoparticulate carrier systems Figueiredo, L.
2012
30 Supplement 4 p. 6551-6558
8 p.
artikel
97 Introduction of Human Papillomavirus DNA Screening in the World: 15 Years of Experience Castle, Philip E.
2012
30 Supplement 4 p. F117-F122
nvt p.
artikel
98 Introduction of human papillomavirus vaccination in Nordic countries Sander, Bente Braad
2012
30 Supplement 4 p. 1425-1433
9 p.
artikel
99 Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada De Wals, Philippe
2012
30 Supplement 4 p. 6416-6420
5 p.
artikel
100 In vitro assessment of halobacterial gas vesicles as a Chlamydia vaccine display and delivery system Childs, Tawanna S.
2012
30 Supplement 4 p. 5942-5948
7 p.
artikel
101 In vitro derivation of interferon-γ producing, IL-4 and IL-7 responsive memory-like CD4+ T cells Comber, Joseph D.
2012
30 Supplement 4 p. 2140-2145
6 p.
artikel
102 Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination Li, Xi
2012
30 Supplement 4 p. 4581-4584
4 p.
artikel
103 Lessons from an online debate about measles–mumps–rubella (MMR) immunization Nicholson, Michelle S.
2012
30 Supplement 4 p. 3806-3812
7 p.
artikel
104 Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis Shargh, Vahid Heravi
2012
30 Supplement 4 p. 3957-3964
8 p.
artikel
105 Maternal antibody parameters of cattle and calves receiving EG95 vaccine to protect against Echinococcus granulosus Heath, David D.
2012
30 Supplement 4 p. 7321-7326
6 p.
artikel
106 Mice immunized with bone marrow-derived dendritic cells stimulated with recombinant Coxiella burnetii Com1 and Mip demonstrate enhanced bacterial clearance in association with a Th1 immune response Xiong, Xiaolu
2012
30 Supplement 4 p. 6809-6815
7 p.
artikel
107 Molecular epidemiology of circulating highly pathogenic avian influenza (H5N1) virus in chickens, in Bangladesh, 2007–2010 Ahmed, Syed Sayeem Uddin
2012
30 Supplement 4 p. 7381-7390
10 p.
artikel
108 Monitoring of rotavirus vaccination in Morocco: Establishing the baseline burden of rotavirus disease Benhafid, Mohammed
2012
30 Supplement 4 p. 6515-6520
6 p.
artikel
109 Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection Cauchard, S.
2011
30 Supplement 4 p. 95-102
8 p.
artikel
110 Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes Kennedy, Richard B.
2012
30 Supplement 4 p. 2159-2167
9 p.
artikel
111 Mumps: Burden of disease in France Coffinières, E.
2012
30 Supplement 4 p. 7013-7018
6 p.
artikel
112 Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008 Snijders, Bianca E.P.
2012
30 Supplement 4 p. 2999-3002
4 p.
artikel
113 Neonatal revaccination with Bacillus Calmette–Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice Li, Wen
2012
30 Supplement 4 p. 3223-3230
8 p.
artikel
114 Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: A 10-year study Charfi, F.
2012
30 Supplement 4 p. G18-G24
nvt p.
artikel
115 One clinic visit for pre-exposure rabies vaccination (a preliminary one year study) Khawplod, Pakamatz
2012
30 Supplement 4 p. 2918-2920
3 p.
artikel
116 Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice Ma, Wen-Jiang
2012
30 Supplement 4 p. 1437-1444
8 p.
artikel
117 Parental and societal values for the risks and benefits of childhood combination vaccines Gidengil, Courtney
2012
30 Supplement 4 p. 3445-3452
8 p.
artikel
118 Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit vaccine Thomas, Brad S.
2012
30 Supplement 4 p. 998-1008
11 p.
artikel
119 Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines Edwards, Morven S.
2012
30 Supplement 4 p. 4123-4126
4 p.
artikel
120 Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations Khatami, Ameneh
2012
30 Supplement 4 p. 2831-2838
8 p.
artikel
121 Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009 Chen, Wilbur H.
2012
30 Supplement 4 p. 4240-4248
9 p.
artikel
122 Plasma beads loaded with Candida albicans cytosolic proteins impart protection against the fungal infection in BALB/c mice Ahmad, Ejaj
2012
30 Supplement 4 p. 6851-6858
8 p.
artikel
123 Pneumococcal disease in South Australia: Vaccine success but no time for complacency Johnson, David R.
2012
30 Supplement 4 p. 2206-2211
6 p.
artikel
124 Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients Chang, Yu-Tzu
2012
30 Supplement 4 p. 5009-5018
10 p.
artikel
125 Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiânia, Brazil Andrade, Ana Lucia
2012
30 Supplement 4 p. 1901-1909
9 p.
artikel
126 Potential impact of accelerating the primary dose of rotavirus vaccine in infants Halvorson, Elizabeth E.
2012
30 Supplement 4 p. 2738-2741
4 p.
artikel
127 Potential impact of parental Tdap immunization on infant pertussis hospitalizations Peters, Timothy R.
2012
30 Supplement 4 p. 5527-5532
6 p.
artikel
128 Preclinical safety assessment of recombinant botulinum vaccine A/B (rBV A/B) Shearer, Jeffry D.
2012
30 Supplement 4 p. 1917-1926
10 p.
artikel
129 Progressive changes in pneumococcal carriage in children attending daycare in Portugal after 6 years of gradual conjugate vaccine introduction show falls in most residual vaccine serotypes but no net replacement or trends in diversity Rodrigues, Fernanda
2012
30 Supplement 4 p. 3951-3956
6 p.
artikel
130 Prophylactic treatment with Toll-like receptor ligands enhances host immunity to avian influenza virus in chickens St. Paul, Michael
2012
30 Supplement 4 p. 4524-4531
8 p.
artikel
131 Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica Arguedas, Adriano
2012
30 Supplement 4 p. 2342-2348
7 p.
artikel
132 Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant Zhou, Huaiyu
2012
30 Supplement 4 p. 1800-1806
7 p.
artikel
133 Protective immune responses to biolistic DNA vaccination of Brugia malayi abundant larval transcript-2 Joseph, S.K.
2012
30 Supplement 4 p. 6477-6482
6 p.
artikel
134 Publication/copyright info 2012
30 Supplement 4 p. v-
1 p.
artikel
135 Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel Ben-Shimol, S.
2012
30 Supplement 4 p. 6600-6607
8 p.
artikel
136 Reduction of high pathogenicity avian influenza virus in eggs from chickens once or twice vaccinated with an oil-emulsified inactivated H5 avian influenza vaccine Swayne, David E.
2012
30 Supplement 4 p. 4964-4970
7 p.
artikel
137 Reframing Cervical Cancer Prevention. Expanding the Field Towards Prevention of Human Papillomavirus Infections and Related Diseases Bosch, F. Xavier
2012
30 Supplement 4 p. F1-F11
nvt p.
artikel
138 Replication and pathogenicity of attenuated human metapneumovirus F mutants in severe combined immunodeficiency mice Yu, Chun-mei
2012
30 Supplement 4 p. 231-236
6 p.
artikel
139 Research priorities for global measles and rubella control and eradication Goodson, James L.
2012
30 Supplement 4 p. 4709-4716
8 p.
artikel
140 Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus Fu, Tong-Ming
2012
30 Supplement 4 p. 7469-7474
6 p.
artikel
141 Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders Hoebe, Christian J.P.A.
2012
30 Supplement 4 p. 6734-6737
4 p.
artikel
142 Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States Krishnarajah, Girishanthy
2012
30 Supplement 4 p. 3717-3722
6 p.
artikel
143 Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients Lertdumrongluk, Paungpaga
2012
30 Supplement 4 p. 1108-1114
7 p.
artikel
144 Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens Stanberry, L.R.
2012
30 Supplement 4 p. 307-316
10 p.
artikel
145 Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults Halperin, Scott A.
2012
30 Supplement 4 p. 5445-5448
4 p.
artikel
146 Safety and immunogenicity of fully liquid DTaP5-IPV-Hib pediatric combination vaccine (Pediacel®) compared to DTaP3-HBV-IPV/Hib (Infanrix® Hexa) when coadministered with heptavalent pneumococcal conjugate vaccine (PCV7) as a booster at 11–18 months of age: A phase III, modified double-blind, randomized, controlled, multicenter study Berner, Reinhard
2012
30 Supplement 4 p. 5270-5277
8 p.
artikel
147 Safety and immunogenicity of 2010–2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12–59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: A PHAC/CIHR Influenza Research Network (PCIRN) study Langley, Joanne M.
2012
30 Supplement 4 p. 3389-3394
6 p.
artikel
148 Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq®, in Kenya, including among HIV-infected and HIV-exposed infants Laserson, Kayla F.
2012
30 Supplement 4 p. A61-A70
nvt p.
artikel
149 Safety of Zostavax™—A cohort study in a managed care organization Baxter, Roger
2012
30 Supplement 4 p. 6636-6641
6 p.
artikel
150 School-located influenza immunization programs: Factors important to parents and students Middleman, Amy B.
2012
30 Supplement 4 p. 4993-4999
7 p.
artikel
151 Simplifying complex sequence information: A PCP-consensus protein binds antibodies against all four Dengue serotypes Bowen, David M.
2012
30 Supplement 4 p. 6081-6087
7 p.
artikel
152 SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses Lai, Lilin
2012
30 Supplement 4 p. 1737-1745
9 p.
artikel
153 Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine Kanagavelu, Saravana K.
2012
30 Supplement 4 p. 691-702
12 p.
artikel
154 Sortase-conjugation generates a capsule vaccine that protects guinea pigs against Bacillus anthracis Garufi, Gabriella
2012
30 Supplement 4 p. 3435-3444
10 p.
artikel
155 Stability of a formalin-inactivated Rift Valley fever vaccine: Evaluation of a vaccination campaign for cattle in Mozambique Lagerqvist, N.
2012
30 Supplement 4 p. 6534-6540
7 p.
artikel
156 Strain impact on equine herpesvirus type 1 (EHV-1) abortion models: Viral loads in fetal and placental tissues and foals Gardiner, David W.
2012
30 Supplement 4 p. 6564-6572
9 p.
artikel
157 Superior protection conferred by inactivated whole virus vaccine over subunit and DNA vaccines against salmonid alphavirus infection in Atlantic salmon (Salmo salar L.) Xu, Cheng
2012
30 Supplement 4 p. 3918-3928
11 p.
artikel
158 The capsule of Streptococcus equi ssp. zooepidemicus is a target for attenuation in vaccine development Wei, Zigong
2012
30 Supplement 4 p. 4670-4675
6 p.
artikel
159 The cationic lipid, diC14 amidine, extends the adjuvant properties of aluminum salts through a TLR-4- and caspase-1-independent mechanism Wilmar, Arnaud
2012
30 Supplement 4 p. 414-424
11 p.
artikel
160 The decision making process on new vaccines introduction in South Africa Ngcobo, Ntombenhle Judith
2012
30 Supplement 4 p. C9-C13
nvt p.
artikel
161 The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: A randomized controlled trial Dagan, Ron
2012
30 Supplement 4 p. 5132-5140
9 p.
artikel
162 The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies Ambrose, Christopher S.
2012
30 Supplement 4 p. 886-892
7 p.
artikel
163 The immune enhancement of a novel soy lecithin/β-glucans based adjuvant on native Neospora caninum tachyzoite extract vaccine in mice Mansilla, Florencia Celeste
2012
30 Supplement 4 p. 1124-1131
8 p.
artikel
164 The impact of new vaccine introduction on immunization and health systems: A review of the published literature Hyde, Terri B.
2012
30 Supplement 4 p. 6347-6358
12 p.
artikel
165 The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture–recapture analysis Huang, Wan-Ting
2012
30 Supplement 4 p. 2168-2172
5 p.
artikel
166 Towards licensing of CP7_E2alf as marker vaccine against classical swine fever—Duration of immunity Gabriel, Claudia
2012
30 Supplement 4 p. 2928-2936
9 p.
artikel
167 Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis Cui, Xia
2012
30 Supplement 4 p. 2282-2287
6 p.
artikel
168 Transmission of a live Eimeria acervulina vaccine strain and response to infection in vaccinated and contact-vaccinated broilers Velkers, Francisca C.
2012
30 Supplement 4 p. 322-328
7 p.
artikel
169 Two decades of hepatitis B vaccination in mentally retarded patients: Effectiveness, antibody persistence and duration of immune memory Braeckman, Tessa
2012
30 Supplement 4 p. 4757-4761
5 p.
artikel
170 Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults Potsch, D.V.
2012
30 Supplement 4 p. 5973-5977
5 p.
artikel
171 Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight Wilson, Stephen
2012
30 Supplement 4 p. 7625-7629
5 p.
artikel
172 Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis Zhang, L.
2012
30 Supplement 4 p. 2301-2308
8 p.
artikel
173 Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): Impact on the timeliness of uptake of the primary course of DTPa vaccine Wendy, Bissinger
2012
30 Supplement 4 p. 5293-5297
5 p.
artikel
174 Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis Agallou, Maria
2012
30 Supplement 4 p. 5086-5093
8 p.
artikel
175 Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection Monney, Thierry
2012
30 Supplement 4 p. 6588-6594
7 p.
artikel
176 Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010–2011: Cohort and case–control study Castilla, Jesús
2012
30 Supplement 4 p. 195-200
6 p.
artikel
177 Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques Bialuk, Izabela
2011
30 Supplement 4 p. 78-94
17 p.
artikel
178 Variation in adult vaccination policies across Europe: An overview from VENICE network on vaccine recommendations, funding and coverage Kanitz, Elisabeth E.
2012
30 Supplement 4 p. 5222-5228
7 p.
artikel
179 Workshop on intussusception in African countries – Meeting report Steele, A. Duncan
2012
30 Supplement 4 p. A185-A189
nvt p.
artikel
                             179 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland